Source - RNS
RNS Number : 0533R
Georgia Healthcare Group PLC
25 February 2019
 

London, 25 February 2019

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Giorgi Mindiashvili

2.

Reason for the notification

a)

Position / status

PDMR, Deputy CEO

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Healthcare Group PLC

b)

LEI:

213800RJGJDDZENQER80

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

ordinary shares of £0.01 each in Georgia Healthcare Group PLC

 

 

 

 

GB00BYSS4K11

 

b)

Nature of the transaction

Exercise of nil-cost options over GHG ordinary shares pursuant to the employee share option programme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

86,609

 

d)

Aggregated information

 

 

Aggregated volume

 

Please note that a total of 17,322 shares were withheld to meet tax liabilities, resulting in the receipt of 69,287 shares.

 

 

Aggregated price

nil

 

 

 

e)

Date of the transactions

20 February 2019

f)

 

Place of the transaction

Outside of a trading venue

 

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: 

Link Company Matters Limited, Company Secretary

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFFEFEIEFIA